20-May-2017 | R | 17:22 Rights Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Zenotech Laboratories Ltd. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Zenotech Laboratories Ltd.
(532039)
RECORD DATE
02/06/2017
PURPOSE
Issue of 17 (SEVENTEEN) equity shares of Rs. 10/- each on rights basis for cash at premium of Rs. 35/- per share for every 22 (TWENTY TWO) equity shares held.
Ex-Right basis from Date & Sett. No.
01/06/2017 DR-043/2017-2018
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 31/05/2017) | 02-Jun-2017 | 17:22 |
17-Oct-2024 | BC | ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial R | 23-Oct-2024 | |
23-Oct-2024 | BC | Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Comp | 23-Oct-2024 | |
23-Aug-2024 | BC | Intimation of 35th Annual General Meeting of the Company will be held on Friday, September 27, 2024 at 10:30 a.m. IST through Video Conferencing.
Voting Results of 35th Annual General Meeting and | 27-Sep-2024 | |
18-Jul-2024 | BC | ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Resul | 26-Jul-2024 | |
17-May-2024 | BC | Resignation of Chief Executive Officer ('Key Managerial Personnel') of Zenotech Laboratories Limited. | 17-May-2024 | |
No Dividends has been declared by Zenotech-Laboratories-Ltd
No Bonus has been declared by Zenotech-Laboratories-Ltd
No Split has been declared by Zenotech-Laboratories-Ltd
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)35
Ratio17:22
Book Closure
23-Oct-2024 | - | ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial R |
23-Oct-2024 | - | Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Comp |
27-Sep-2024 | - | Intimation of 35th Annual General Meeting of the Company will be held on Friday, September 27, 2024 at 10:30 a.m. IST through Video Conferencing.
Voting Results of 35th Annual General Meeting and |
26-Jul-2024 | - | ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Resul |
17-May-2024 | - | Resignation of Chief Executive Officer ('Key Managerial Personnel') of Zenotech Laboratories Limited. |